Merial drug adds claims

Article

Previcox controls pain and inflammation.

Merial announced that the company has received FDA approval to expand the label claim for Previcox, a canine osteoarthritis pain reliever. The expanded label claim includes the control of postoperative pain and inflammation associated with soft-tissue surgery in dogs. For more, visit previcox.com.

Recent Videos
Gianluca Bini, DVM, MRCVS, DACVAA
Related Content
© 2024 MJH Life Sciences

All rights reserved.